LEFTY1
Basic information
Region (hg38): 1:225886282-225911382
Previous symbols: [ "LEFTB" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (70 variants)
- not_provided (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LEFTY1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000020997.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 66 | 71 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 66 | 7 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LEFTY1 | protein_coding | protein_coding | ENST00000272134 | 4 | 25101 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.68e-13 | 0.0113 | 125675 | 1 | 42 | 125718 | 0.000171 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.738 | 204 | 236 | 0.865 | 0.0000152 | 2306 |
Missense in Polyphen | 56 | 62.647 | 0.89389 | 641 | ||
Synonymous | 1.42 | 97 | 117 | 0.832 | 0.00000828 | 799 |
Loss of Function | -0.603 | 17 | 14.5 | 1.17 | 7.78e-7 | 134 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000410 | 0.000409 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000517 | 0.0000462 |
European (Non-Finnish) | 0.000154 | 0.000150 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000233 | 0.000229 |
Other | 0.000509 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Required for left-right axis determination as a regulator of LEFTY2 and NODAL.;
- Pathway
- TGF-beta signaling pathway - Homo sapiens (human);Cell Differentiation - Index expanded;Cell Differentiation - Index;Differentiation Pathway;Mesodermal Commitment Pathway;TGF-beta Receptor Signaling;Developmental Biology;Regulation of signaling by NODAL;Signaling by NODAL
(Consensus)
Recessive Scores
- pRec
- 0.472
Intolerance Scores
- loftool
- 0.538
- rvis_EVS
- 1.42
- rvis_percentile_EVS
- 94.86
Haploinsufficiency Scores
- pHI
- 0.520
- hipred
- N
- hipred_score
- 0.187
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.197
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lefty1
- Phenotype
- cellular phenotype; growth/size/body region phenotype; respiratory system phenotype; liver/biliary system phenotype; renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;heart morphogenesis;transforming growth factor beta receptor signaling pathway;determination of left/right symmetry;regulation of signaling receptor activity;positive regulation of pathway-restricted SMAD protein phosphorylation;regulation of apoptotic process;regulation of MAPK cascade;cell development;SMAD protein signal transduction
- Cellular component
- extracellular space
- Molecular function
- cytokine activity;transforming growth factor beta receptor binding;growth factor activity